Posts

Showing posts with the label Biologics Market Forecast

Biologics Market 2022 Market Competitive Landscape Analysis

Biologics or biological products are substances comprising of sugars, nucleic acids, proteins or complex combinations of these materials  as well as living entities such as tissues and  cells. Compared to conventional chemical drugs, biologics are relatively complex molecules. Biologics are derived from different natural sources such as animals, humans or microorganisms and usually consist of blood components, allergenics, tissues, somatic cells along with recombinant therapeutic proteins. Commonly known biologics are enbrel, remicade, avonex, humira, betaseron and Herceptin to name a few. Biologics have revolutionized the treatment of chronic disorders such as psoriasis, rheumatoid arthritis, psoriatic arthritis, multiple sclerosis and Crohn’s disease along with a variety of cancers. Like drugs, biologics are used to cure or treat medical conditions and diseases, prevent diseases or to diagnose diseases. Some of the biologics and their approved uses include: Botox for ...